Aytu Biopharma (AYTU) Return on Sales [ROS] (2013 - 2026)
Aytu Biopharma's Return on Sales [ROS] was -4.82% in fiscal Q4 2026 (quarter ended Jun 30, 2026), up 45.54 percentage points from -50.37% a year earlier and up 27.92 percentage points from the prior quarter.
Powered by 
Analysis
Aytu Biopharma (AYTU) Return on Sales [ROS] (2013 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Return on Sales [ROS] at Aytu Biopharma came in at -14.44%, down 2.65 percentage points from FY2025.
- Return on Sales [ROS] shows a five-year change of +75.25 percentage points (FY2021 to FY2026).
- In earlier fiscal years, Return on Sales [ROS] was -11.79% in FY2025 (-9.35 pp), -2.44% in FY2024 (+13.45 pp), -15.89% in FY2023 (+97.80 pp) and -113.69% in FY2022 (-24.00 pp).
- The fiscal Q4 2026 figure marks the highest quarterly Return on Sales [ROS] since fiscal Q3 2025.
- Compared with a year earlier, Return on Sales [ROS] was higher in two of the last eight quarters, with an average year-over-year change of -5.79 percentage points.
- The best year-over-year quarter for Return on Sales [ROS] over five years was fiscal Q3 2023 (a gain of 183.11 percentage points); the worst was fiscal Q1 2022 (a drop of 100.19 percentage points).
- Per Business Quant data, AYTU's Return on Sales [ROS] in the three fiscal quarters before Q4 2026 was -32.75% (Q3 2026), -12.99% (Q2 2026) and -10.83% (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Aytu Biopharma | 22.49 Mn | -93.18 Mn | 10.41 Mn | -4.82% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4.82% |
| Mar 31, 2026 | -32.75% |
| Dec 31, 2025 | -12.99% |
| Sep 30, 2025 | -10.83% |
| Jun 30, 2025 | -50.37% |
| Mar 31, 2025 | 13.12% |
| Dec 31, 2024 | -10.45% |
| Sep 30, 2024 | -5.61% |
| Jun 30, 2024 | -15.58% |
| Mar 31, 2024 | -11.39% |
| Dec 31, 2023 | 16.78% |
| Sep 30, 2023 | -4.87% |
| Jun 30, 2023 | 0.55% |
| Mar 31, 2023 | -37.65% |
| Dec 31, 2022 | -26.13% |
| Sep 30, 2022 | -6.54% |
| Jun 30, 2022 | -61.72% |
| Mar 31, 2022 | -220.76% |
| Dec 31, 2021 | -48.84% |
| Sep 30, 2021 | -126.50% |
API Access
Aytu Biopharma Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=AYTU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "AYTU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=AYTU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();